Feedback / Questions
EP395 - EpiEndo Pharma
https://www.businesswire.com/news/home/20240410505161/en/EpiEndo-reports-Phase-2A-results-for-lead-asset-EP395-in-COPD
Apr 10, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next